Bone Biologics (BBLGW) Total Current Liabilities (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Total Current Liabilities for 2 consecutive years, with $3.8 million as the latest value for Q3 2017.

  • Quarterly Total Current Liabilities rose 1038.07% to $3.8 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Sep 2017, up 1038.07% year-over-year, with the annual reading at $1.5 million for FY2016, N/A changed from the prior year.
  • Total Current Liabilities for Q3 2017 was $3.8 million at Bone Biologics, up from $2.7 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $3.8 million in Q3 2017, with the low at $335622.0 in Q3 2016.